$142.58
+0.10
(+0.07%)
As of Oct 7, 2026, 3:05 PM EDT
Price history
Today's analyst average
Analyst average over timeIndividual analyst targets
Analyst history starts Jul 22, 2026, the first target we tracked for EFX.
Equifax (EFX) is trading up at $142.58 (+0.07%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Industrials sector.
Analyst price targets on EFX
Current price targets from 2 firms average $215, ranging from $194 to $235 — 50% above the current $143. Each is tracked to its date and scored the same way a member's call is.
- Rothschild & Co Redburn $193 → $235 by Aug 2027 Aug 21, 2026 via Investing.com · Rothschild & Co Redburn's track record
- RBC Capital Markets $170 → $194 by Jul 2027 Jul 22, 2026 via Investing.com · RBC Capital Markets's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Equifax revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.14B | $3.36B | $3.41B | $3.51B | $4.13B | $4.92B | $5.12B | $5.27B | $5.68B | $6.07B |
| Growth (year over year) | +18.1% | +6.9% | +1.5% | +2.8% | +17.7% | +19.3% | +4.0% | +2.8% | +7.9% | +6.9% |
| Gross profit | $2.03B | $2.15B | $1.97B | $1.99B | $2.39B | $2.94B | $2.94B | $2.93B | $3.16B | $3.43B |
| Gross margin | 64.6% | 64.0% | 57.8% | 56.6% | 57.9% | 59.8% | 57.5% | 55.7% | 55.7% | 56.4% |
| Operating income | $825.1M | $831.7M | $448.0M | −$335.4M | $676.6M | $1.14B | $1.06B | $933.6M | $1.04B | $1.10B |
| Operating margin | 26.2% | 24.7% | 13.1% | −9.6% | 16.4% | 23.1% | 20.6% | 17.7% | 18.3% | 18.0% |
| Net income | $488.8M | $587.3M | $310.5M | −$384.1M | $520.1M | $744.2M | $696.2M | $545.3M | $604.1M | $660.3M |
| Net margin | 15.5% | 17.5% | 9.1% | −11.0% | 12.6% | 15.1% | 13.6% | 10.4% | 10.6% | 10.9% |
| EPS (diluted) | $4.04 | $4.83 | $2.56 | −$3.15 | $4.24 | $6.02 | $5.65 | $4.40 | $4.84 | $5.32 |
| Balance sheet | ||||||||||
| Cash and equivalents | $129.3M | $336.4M | $223.6M | $401.3M | $1.68B | $224.7M | $285.2M | $216.8M | $169.9M | $180.8M |
| Total assets | $6.66B | $7.23B | $7.15B | $7.91B | $9.61B | $11.0B | $11.5B | $12.3B | $11.8B | $11.9B |
| Total liabilities | $3.94B | $3.99B | $4.00B | $5.29B | $6.40B | $7.44B | $7.57B | $7.59B | $6.84B | $7.13B |
| Long-term debt | $2.09B | $1.74B | $2.63B | $3.38B | $3.28B | $4.47B | $4.82B | $4.75B | $4.32B | $4.06B |
| Shareholders' equity | $2.66B | $3.17B | $3.11B | $2.58B | $3.17B | $3.58B | $3.96B | $4.53B | $4.80B | $4.60B |
| Cash flow | ||||||||||
| Operating cash flow | $823.0M | $816.0M | $672.2M | $313.8M | $946.2M | $1.33B | $757.1M | $1.12B | $1.32B | $1.62B |
| Capital expenditure | $173.5M | $218.2M | $321.9M | $399.6M | $421.3M | $469.0M | $624.5M | $601.3M | $511.5M | $481.4M |
| Free cash flow | $649.5M | $597.8M | $350.3M | −$85.8M | $524.9M | $865.8M | $132.6M | $515.5M | $813.0M | $1.13B |
| Dividends paid | $157.6M | $187.4M | $187.9M | $188.7M | $189.5M | $190.0M | $191.1M | $191.8M | $193.2M | $232.8M |
| Share buybacks | $0 | $77.1M | $0 | $0 | $0 | $69.9M | $0 | $0 | $0 | $927.5M |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.44B | $1.42B | $1.44B | $1.54B | $1.54B | $1.55B | $1.65B | $1.70B |
| Growth (year over year) | +9.3% | +7.0% | +3.8% | +7.4% | +7.2% | +9.2% | +14.3% | +10.6% |
| Gross profit | $796.6M | $804.5M | $785.3M | $872.4M | $881.7M | $889.5M | $881.8M | $926.4M |
| Gross margin | 55.3% | 56.7% | 54.5% | 56.8% | 57.1% | 57.4% | 53.5% | 54.5% |
| Operating income | $247.1M | $288.1M | $235.8M | $310.8M | $264.3M | $284.3M | $287.7M | $314.2M |
| Operating margin | 17.1% | 20.3% | 16.4% | 20.2% | 17.1% | 18.3% | 17.4% | 18.5% |
| Net income | $141.3M | $174.0M | $133.1M | $191.3M | $160.2M | $175.7M | $171.5M | $183.9M |
| Net margin | 9.8% | 12.3% | 9.2% | 12.4% | 10.4% | 11.3% | 10.4% | 10.8% |
| EPS (diluted) | $1.13 | $1.40 | $1.06 | $1.53 | $1.29 | $1.44 | $1.42 | $1.54 |
| Balance sheet | ||||||||
| Cash and equivalents | $468.2M | $169.9M | $195.2M | $189.0M | $189.0M | $180.8M | $183.4M | $170.1M |
| Total assets | $12.3B | $11.8B | $11.9B | $11.9B | $11.8B | $11.9B | $11.9B | $12.0B |
| Total liabilities | $7.30B | $6.84B | $6.74B | $6.68B | $6.76B | $7.13B | $7.26B | $7.46B |
| Long-term debt | $4.72B | $4.32B | $4.32B | $4.05B | $4.05B | $4.06B | $4.06B | $4.06B |
| Shareholders' equity | $4.91B | $4.80B | $4.98B | $5.10B | $4.94B | $4.60B | $4.54B | $4.38B |
| Cash flow | ||||||||
| Operating cash flow | $479.5M | $324.8M | $223.9M | $361.1M | $559.9M | $470.8M | $241.9M | $339.8M |
| Capital expenditure | $124.0M | $118.9M | $107.2M | $122.2M | $122.0M | $130.0M | $120.4M | $135.0M |
| Free cash flow | $355.5M | $205.9M | $116.7M | $238.9M | $437.9M | $340.8M | $121.5M | $204.8M |
| Dividends paid | $48.4M | $48.4M | $48.5M | $62.0M | $61.5M | $60.8M | $67.1M | $66.4M |
| Share buybacks | $0 | $0 | $0 | $127.4M | $300.0M | $500.1M | $260.0M | $300.0M |
From Equifax's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Equifax
Equifax Inc. is an American multinational consumer credit reporting agency headquartered in Atlanta, Georgia, and is one of the three largest consumer credit reporting agencies, along with Experian and TransUnion. Equifax collects and aggregates information on more than 800 million individual consumers and more than 88 million businesses worldwide. In addition to credit and demographic data and services to business, Equifax sells credit monitoring and fraud prevention services directly to consumers.
- Headquarters
- Atlanta, Georgia From SEC filings, Oct 2026
Recent News (20)
-
Equifax Announces Earnings Release Date and Conference Call for Third Quarter 2026 Results ATLANTA, Oct. 6, 2026 /PRNewswire/ -- Equifax® (NYSE: EFX) will announce its financial results for the third quarter ended September 30, 2026, in a release to be issued on Tuesday, October 20, at 6:30…
-
Equifax and TransUnion shares fall on mortgage credit report rule change
Equifax and TransUnion shares fall on mortgage credit report rule change
-
Equifax (EFX) Stock Trades Up, Here Is Why Equifax (EFX) Stock Trades Up, Here Is Why StockStory
-
Enerflex Ltd. Announces Contract Award for Large-Scale Data Center Development CALGARY, Alberta, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announces the award of a major Engineered Systems (“ES”) project. The Co…
-
Enerflex Ltd. Completes Asia Pacific Divestiture and Confirms Timing of Third Quarter Financial and Operational Results CALGARY, Alberta, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) has completed the previously announced divestiture of the majority of its ope…
-
Equifax Second Quarter 2026 Market Pulse Index Report Sees First Pause in K-Shaped Economic Widening in Three Years Measure of U.S. Consumer Financial Health Shows Modest Improvement In Consumer Financial Position Over Previous Quarter The Q2 2026 Equifax Market Pulse Index rose marginally to 61.3, marking the firs…
-
Equifax stock hits 52-week low at 150.63 USD
Equifax stock hits 52-week low at 150.63 USD
-
-
Equifax introduces Healthcare Report™ Credential ID New solution designed to help streamline healthcare provider onboarding and better safeguard patient care ATLANTA, Sept. 22, 2026 /PRNewswire/ -- Equifax® (NYSE:EFX) today announced the launch of Heal…
-
Is Equifax Stock Outperforming the Dow?
Is Equifax Stock Outperforming the Dow?
-
Creditsafe Joins SBFE's Partner Ecosystem, Extending the Use of SBFE Data to Suppliers and Vendors for Small Businesses CLEVELAND, Sept. 15, 2026 /PRNewswire/ -- The Small Business Financial Exchange (SBFE) and Creditsafe today announced that Creditsafe has joined the SBFE partner ecosystem, alongside Dun & Bradstreet,…
-
-
Why is Equifax stock sliding today?
Why is Equifax stock sliding today?
-
Pulte accuses Equifax, Experian, TransUnion of overcharging Americans
Pulte accuses Equifax, Experian, TransUnion of overcharging Americans
-
What Are Wall Street Analysts' Target Price for Equifax Stock?
What Are Wall Street Analysts' Target Price for Equifax Stock?
-
-
Rothschild Redburn upgrades Equifax stock rating on cloud execution
Rothschild Redburn upgrades Equifax stock rating on cloud execution
-
-
-
More Industrials stocks
- CTAS Cintas
- DAL Delta Air Lines
- DE Deere & Company
- DOV Dover Corporation
- EME Emcor
- EMR Emerson Electric
- ETN Eaton Corporation
- EXPD Expeditors International